Ryuichi Moriya

Ryuichi Moriya is the Vice President and Head of Immuno-Oncology at Astellas Pharma, where responsibilities include developing research strategies and leading a research team focused on innovative cancer treatments. With extensive experience, Moriya has previously held positions including Executive Director for cell therapy initiatives and Senior Director for Advanced Biologics, contributing to strategic planning and collaboration with global biotech partners. Prior roles at Astellas involved research portfolio analysis and antibody discovery leadership, alongside a tenure at Agensys, Inc. as a Scientist focused on antibody-drug conjugates. Moriya's career began at Merck as a Pharmacologist, and academic credentials include a Master's degree and a Ph.D. in Pharmaceutics and Drug Design from Hokkaido and Chiba Universities.